Vortioxetine Catalog No.:M10129-10 Nateglinide is an insulin secretagog

Nateglinide is an insulin secretagog agent used for the treatment of non-insulin-dependent diabetes mellitus (NIDDM)

CVT-10216 prevents alcohol-induced increases in NAc DA without changing basal levels

is a potent mTOR inhibitor

11(12):1530-41

Vortioxetine Catalog No.:M10129-10 Nateglinide is an insulin secretagogVortioxetine, also known as Lu AA21004, is an atypical antidepressant, and was approved in 2013 by the U. S. FDA for the treatment of major depressive disorder (MDD) in adults. Vortioxetine is a so called "serotonin modulator and stimulator." It has been shown to possess the following pharmacological actions: Serotonin transporter (SERT) blocker (i. e. serotonin reuptake inhibitor (SRI)) Ki (binding affinity) = 1. 6 nM, IC50 = 5. 4 nM; Norepinephrine